Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ

David F. Fiorentino, Lorinda S. Chung, Lisa Christopher-Stine, Lisa Zaba, Shufeng Li, Andrew L. Mammen, Antony Rosen, Livia Casciola-Rosen

Research output: Contribution to journal › Article › peer-review

209 Scopus citations

Fingerprint

Dive into the research topics of 'Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ'. Together they form a unique fingerprint.

Medicine & Life Sciences